United States · FDA National Drug Code directory
Doxepin hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2092_db2e0d46-5dac-48bd-8aca-4fd5ae1b463b
- Product NDC
- 71335-2092
- Form
- CAPSULE
- Composition / generic term
- Doxepin hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191220
- Source listing expiry
- 20261231
Source-listed ingredients
- DOXEPIN HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (71335-2092-1) · 71335-2092-1
- 60 CAPSULE in 1 BOTTLE (71335-2092-2) · 71335-2092-2
- 18 CAPSULE in 1 BOTTLE (71335-2092-3) · 71335-2092-3
- 90 CAPSULE in 1 BOTTLE (71335-2092-4) · 71335-2092-4
- 180 CAPSULE in 1 BOTTLE (71335-2092-5) · 71335-2092-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →